FRS-006 Long-Term Follow-Up Patients with ST-Segment Elevation Acute Myocardial Infarction Treated with Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent(Strategies to Acute Myocardial Infarction-2 (IHD) FRS2,Featured Research Session,The 70th Annivers
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本循環器学会の論文
- 2006-03-01
著者
-
Wasan Udayachalerm
King Chulalongkorn Memorial Hospital
-
Sudaratana Tansuphaswadikul
Chest Disease Institute
-
Hans Cahyadi
Husada Hospital
-
Bae Jang-Ho
Konyang University Hospital
-
Hans Cahyadi
Department Of Cardiology Husada Hospital
-
Bae Jang-ho
Department Of Cardiology Konyang University Hospital
-
Nakamura Sunao
New Tokyo Hospital
-
Nakamura Shotaro
Secomedic Hospital
-
Udayachalerm Wasan
King Chulalongkorn Memorial Hospital
-
Tansuphaswadikul Sudaratana
Chest Disease Institute
-
Damras Tresukosol
Siriraj Hospital
-
Damras Tresukosol
Her Majesty's Cardiac Center Siriraj Hospital
関連論文
- PJ-123 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Diffuse In-Stent Restenosis : Multicenter Registry in Asia(PJ021,Coronary Revascularization, PCI (Complex Lesions) (IHD),Poster Session (Japanese),The 73rd Annual Scienti
- PJ-122 Drug-Eluting Stents for the Treatment of CTO : A Comparison with Sirolimus, Paclitaxel, Zotarolimus, EPC Capture and Everolimus-Eluting Stent: Multicenter Registry(PJ021,Coronary Revascularization, PCI (Complex Lesions) (IHD),Poster Session (Japane
- OJ-125 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Long Coronary Lesions : Multicenter Registry in Asia(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientifi
- OJ-124 Comparison of 4Years Efficacy and Durability of DES Implantation in Non-bifurcation and Bifurcation Lesion of Unprotected LMT : Multicenter Registry(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73r
- OJ-123 Systematic Double Stenting versus Simple Provisional T-stenting for True Bifurcation Lesions of LMT Disease Using Drug Eluting Stents : Multicenter Registry(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese)
- OJ-122 Impact of Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Sirolimus-Eluting Stent Failure : Multicenter Registry in Asia(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese
- OJ-039 Drug-Eluting Stents for the Treatment of Left Main Coronary Artery Disease with Sirolimus, Paclitaxel, Zotarolimus, EPC Capture and Everolimus-Eluting Stent(OJ07,Coronary Revascularization, PCI (Complex Lesions) 1 (IHD),Oral Presentation (Japanese)
- OJ-038 Comparison of 4 Years Efficacy and Durability of SES and PES Deployment in Patients with Very Long Coronary Lesions(OJ07,Coronary Revascularization, PCI (Complex Lesions) 1 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of Th
- 1 Low Incidence of Stent Thrombosis in Asian Races : Multicenter Registry in Asia 3 Years Follow-Up Result(Current Status and Future Perspective of Drug-Eluting Stents,Plenary Session 1 (PL-1) (A),The 73rd Annual Scientific Meeting of The Japanese Circula
- PJ-123 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Diffuse In-Stent Restenosis : Multicenter Registry in Asia(PJ021,Coronary Revascularization, PCI (Complex Lesions) (IHD),Poster Session (Japanese),The 73rd Annual Scienti
- PJ-122 Drug-Eluting Stents for the Treatment of CTO : A Comparison with Sirolimus, Paclitaxel, Zotarolimus, EPC Capture and Everolimus-Eluting Stent: Multicenter Registry(PJ021,Coronary Revascularization, PCI (Complex Lesions) (IHD),Poster Session (Japane
- OJ-125 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Long Coronary Lesions : Multicenter Registry in Asia(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientifi
- OJ-124 Comparison of 4Years Efficacy and Durability of DES Implantation in Non-bifurcation and Bifurcation Lesion of Unprotected LMT : Multicenter Registry(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73r
- OJ-123 Systematic Double Stenting versus Simple Provisional T-stenting for True Bifurcation Lesions of LMT Disease Using Drug Eluting Stents : Multicenter Registry(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese)
- OJ-122 Impact of Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Sirolimus-Eluting Stent Failure : Multicenter Registry in Asia(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese
- OJ-039 Drug-Eluting Stents for the Treatment of Left Main Coronary Artery Disease with Sirolimus, Paclitaxel, Zotarolimus, EPC Capture and Everolimus-Eluting Stent(OJ07,Coronary Revascularization, PCI (Complex Lesions) 1 (IHD),Oral Presentation (Japanese)
- OJ-038 Comparison of 4 Years Efficacy and Durability of SES and PES Deployment in Patients with Very Long Coronary Lesions(OJ07,Coronary Revascularization, PCI (Complex Lesions) 1 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of Th
- 1 Low Incidence of Stent Thrombosis in Asian Races : Multicenter Registry in Asia 3 Years Follow-Up Result(Current Status and Future Perspective of Drug-Eluting Stents,Plenary Session 1 (PL-1) (A),The 73rd Annual Scientific Meeting of The Japanese Circula
- PJ-296 Percutaneous Coronary Intervention for Acute Myocardial Infarction in the Elderly : Comparison on Clinical Outcome between Younger Patients, Septuagenarians and Octogenarians(Acute myocardial infarction, clinical (diagnosis/treatment)-8 (IHD) PJ50,
- OJ-392 Durability of Endoluminal Stenting for Obstructive Lesions of the Subclavian Artery : Multicenter Registry in Japan(Peripheral circulation-2 (H) OJ66,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circul
- OJ-141 Coronary Artery Perforations : Incidence, Predictors and Clinical Outcomes : Multicenter Registry in Japan(Coronary revascularization, PCI-6 (IHD) OJ24,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circ
- Percutaneous Coronary Intervention in the Elderly : Comparison on Clinical Outcome between Younger (≥70years), Septuagenarians (70-79years) and Octogenarians (>80years)
- Treatment of Total Occluslve Diffuse In-Stent Restenosis
- Initial and Long-Term Clinical Result of Endoluminal Stenting for Obstructive Lesions of the Subclavian Artery
- Stenting of Coronary Bifurcation Lesions : Y-Stenting, T-Stenting, Single Stenting, Immediate and Long-Term Results : Multicenter Registry in Japan
- Impact of Diabetes Mellitus on Initial and Long-Term Clinical Results of Diffuse In-Stent Restenosis in Coronary Artery
- Comparison of Efficacy Between Sirolimus-Eluting Stent (Cypher^) and Paclitaxel-Eluting Stent (TAXUS^) in Unprotected Left Main Coronary Arteries (Angina Pectoris, Basic/Clinical 4 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulat
- One-Year Clinical Outcome of Cypher Sirolimus-Eluting Stents in Patients with Long Coronary Lesions : Multicenter Registry in Asia (Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 8 (IHD), The 69th Annual Scientific Meeting of the Japanes
- Comparison of Efficacy Between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Chronic Total Occlusions (Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 8 (IHD), The 69th Annual Scientific Meeting of t
- Durable Clinical Benefit Following Sirolimus-Eluting Stent Deployment on the Outcome of Patients with Unprotected Left Main Coronary Arteries 2-Year Results(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 17 (IHD), The 69th Annual Scienti
- Impact of Sirolimus-Eluting Stents on the One-Year Outcome of Patients with Bifurcation Lesions : Multicenter Registry in Asia(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 17 (IHD), The 69th Annual Scientific Meeting of the Japanese Ci
- Durable Clinical Benefit Following Sirolimus-Eluting Stent Deployment on the Outcome of Patients with Diffuse In-Stent Restenosis : Multicenter Registry in Asia(Angina Pectoris, Basic/Clinical 5 (IHD), The 69th Annual Scientific Meeting of the Japanese Ci
- Durable Clinical Benefit Following Sirolimus-Eluting Stent (Cypher^) Deployment on the Outcome of Patients with Chronic Total Occlusions 2-Year Results(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 9 (IHD), The 69th Annual Scientifi
- Comparison of Efficacy between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Diffuse In-Stent Restenosis(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 3 (IHD), The 69th Annual Scientific Meeting of
- OJ-110 Initial Clinical Experience of Cypher Stents in Unprotected Left Main Coronary Arteries(Coronary Revascularization, PICA/Stent/DCA/Rotablator/New Device 2 (IHD) : OJ14)(Oral Presentation (Japanese))
- FRS-182 Impact of Sirolimus-Eluting Stents on the Outcome of Patients with Chronic Total Occlusions : Multicenter Registry in Asia(Percutaneous Coronary Intervention (IHD) : FRS21)(Featured Research Session (English))
- 非保護左冠動脈主幹部病変に対するsirolimus-eluting stentの短期および長期臨床成績 : Multicenter Registry in Asia(1.薬剤溶出性ステント以後のPCI治療戦略,第70回日本循環器学会学術集会)
- Randomized Comparison of Cilostazol vs Clopidogrel After Drug-Eluting Stenting in Diabetic Patients : CIilostazol for Diabetic Patients in Drug-Eluting Stent (CIDES) Trial
- 4 Comparison of Efficacy and Durability between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent in Unprotected Left Main Coronary Arteries(Plenary Session 1 (PL-1) (IHD) Drug-Eluting Stents : Long-Term Effects and Emerging Problems,Special Program,Th
- PJ-771 Diabetic Patients Requiring Insulin Therapy Have Worse Clinical Outcome after Drug-Eluting Stent Implantation : Multicenter Registry in Asia(Diabetes/Obesity/Metabolic syndrome-11, The 71st Annual Scientific Meeting of the Japanese Circulation Soci
- PJ-753 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Diffuse In-Stent Restenosis : Multicenter Registry in Asia(Coronary revascularization, PCI-22, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-732 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Long Coronary Lesions : Multicenter Registry in Asia(Coronary revascularization, PCI-18, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-728 Drug-Eluting Stents for the Treatment of Chronic Total Occlusion : A Comparison with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-Eluting Stent(Coronary revascularization, PCI-18, The 71st Annual Scientific Meeting of the Japanese Circulation
- PJ-603 Impact of Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Sirolimus-Eluting Stent Failure : Multicenter Registry in Asia(Coronary revascularization, PCI-16, The 71st Annual Scientific Meeting of the Japanese Cir
- PJ-602 Comparison of Efficacy and Safety between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent in Patients with Diffuse In-Stent Restenosis(Coronary revascularization, PCI-16, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-596 Drug-Eluting Stents for the Treatment of Very Long Coronary Artery Stenosis : A Comparison with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-Eluting Stent(Coronary revascularization, PCI-15, The 71st Annual Scientific Meeting of the Japanese C
- PJ-595 Drug-Eluting Stent for the Treatment of Small Coronary Artery with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-Eluting Stent(Coronary revascularization, PCI-15, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-594 Drug-Eluting Stents for the Treatment of Left Main Coronary Arteries with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-Eluting Stent(Coronary revascularization, PCI-14, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-590 Impact of Sirolimus-Eluting Stents on the One-Year Outcome of Patients with Bifurcation Lesions : Multicenter Registry in Asia(Coronary revascularization, PCI-14, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- FRS-008 Durable Clinical Benefit Following Sirolimus-Eluting Stent Deployment in Patients with Unprotected Left Main Arteries : Multicenter Registry in Asia 4-Year Results(Coronary Revascularization (clinical) 1, The 71st Annual Scientific Meeting of the
- 2 Drug-Eluting Stents for the Treatment of Left Main Coronary Artery Disease with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-Eluting Stent(Strategies for Treatment of Left Main Trunk Disease, The 71st Annual Scientific Meeting of the Japanese Circu
- Long Segmental Reconstruction of LAD with Onlay Patch Graft Using an Internal Mammary Artery
- FRS-119 The Effect of Drug-Eluting Stents on Clinical and Angiographic Outcomes in Diabetic Patients : Multicenter Registry in Asia(Coronary Revascularization (clinical) 2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-420 Durable Clinical Benefit Following Paclitaxel-eluting Stent Deployment on the Outcome of Patients with Diffuse In-stent Restenosis : Multicenter Registry 2-year Results(Restenosis, basic/clinical-5 (IHD) PJ71,Poster Session (Japanese),The 70th Anni
- OJ-158 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Long Coronary Lesions : Multicenter Registry in Asia(Chronic coronary heart disease/Remodeling-2 (IHD) OJ27,Oral Presentation (Japanese),The 70th Anniversary Annual Scien
- PJ-010 Three-Year Follow-Up Patients with ST Segment Elevation Acute Myocardial Infarction Treated with Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent : Multicenter Registry in Asia(Acute myocardial infarction, clinical (diagnosis/treatment)-5, The
- PJ-419 Durable Clinical Benefit Following Sirolimus-eluting Stent Deployment on the Outcome of Patients with Diffuse In-stent Restenosis : Multicenter Registry 3-year Results(Restenosis, basic/clinical-5 (IHD) PJ71,Poster Session (Japanese),The 70th Anniv
- PJ-354 Durable Clinical Benefit Following Sirolimus-eiuting Stent on the Outcome of Patients with Unprotected Left Main Coronary Arteries : Multicenter-registry 3-year Results(Coronary revascularization, PCI-15 (IHD) PJ60,Poster Session (Japanese),The 70t
- OJ-234 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Diffuse In-Stent Restenosis : Multicenter Registry in Asia(Restenosis, basic/clinical-2 (IHD) OJ39,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Mee
- OJ-233 Comparison of Efficacy and Safety between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Diffuse In-Stent Restenosis(Restenosis, basic/clinical-2 (IHD) OJ39,Oral Presentation (Japanese),The 70th Anniversary Ann
- OJ-161 Durable Clinical Benefit Following Sirolimus-Eluting Stent Deployment on the Outcome of Patients with Chronic Total Occlusions : Multicenter Registry 3-Year Results(Chronic coronary heart disease/Remodeling-2 (IHD) OJ27,Oral Presentation (Japanese)
- OJ-098 Durable Clinical Benefit Following Paclitaxel-Eluting Stent on the Outcome of Patients with Very Long Coronary Lesions : Multicenter Registry 2-Year Results(Coronary revascularization, PCI-5 (IHD) OJ17,Oral Presentation (Japanese),The 70th Annivers
- FRS-006 Long-Term Follow-Up Patients with ST-Segment Elevation Acute Myocardial Infarction Treated with Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent(Strategies to Acute Myocardial Infarction-2 (IHD) FRS2,Featured Research Session,The 70th Annivers
- 4 Durable Clinical Benefit Following Several Sirolimus-Eluting Stenting on the Outcome of Patients with Unprotected Left Main Coronary Arteries(New Strategy of Coronary Intervention in DES Era,Plenary Session 1 (PL1) (IHD),The 70th Anniversary Annual Scie
- Gabapentin Effect on Neuropathic Pain Compared Among Patients With Spinal Cord Injury and Different Durations of Symptoms
- FRS-083 Durable Clinical Benefit Following Sirolimus-eluting Stent on the Outcome of Patients with Very Long Coronary Lesions : Multicenter Registry 2-year Results(New PCI-2 (IHD) FRS17,Featured Research Session (English),The 70th Anniversary Annual Scien
- FRS-081 Impact of Sirolimus-eluting Stents on the One-year Outcome of Patients with Bifurcation Lesions : Multicenter Registry in Asia(New PCI-2 (IHD) FRS17,Featured Research Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese
- PJ-512 Comparison of Efficacy between Sirolimus-eluting Stent and Paclitaxel-eluting Stent on the Outcome of Patients with Chronic Total Occlusions(Chronic coronary heart disease/Remodeling-4 (IHD) PJ86,Poster Session (Japanese),The 70th Anniversary Annua
- OJ-030 Impact of Sirolimus-Eluting Stents on the Outcome of Patients with Diffuse In-Stent Restenosis : Multicenter Registry in Asia(Restenosis, basic/clinical-1 (IHD) OJ5,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the
- OJ-009 Impact of Paclitaxel-Eluting Stents on the One-year Outcome of Patients with Bifurcation Lesions : Multicenter Registry in Asia(Coronary revascularization, PCI-4 (IHD) OJ2,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting
- OJ-008 Comparison of Efficacy and Safety between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent in Unprotected Left Main Coronary Arteries(Coronary revascularization, PCI-4 (IHD) OJ2,Oral Presentation (Japanese),The 70th Anniversary Annual Scientifi
- OJ-007 Durable Clinical Benefit Following Paclitaxel-Eluting Stent on the Outcome of Patients with Unprotected Left Main Coronary Arteries : Multicenter-Registry 2-year Results(Coronary revascularization, PCI-4 (IHD) OJ2,Oral Presentation (Japanese),The 7
- FRS-109 Comparison of Efficacy and Safety Between Sirolimus-eluting Stent and Paclitaxel-eluting Stent in Patients with Diabetes Mellitus : Multicenter-registry in Asia(Progress in Preventive Medicine-2 (H) FRS22,Featured Research Session (English),The 70
- PJ-508 Comparison of Efficacy and Safety between Sirolimus-eluting Stent and Paclitaxel-eluting Stent on the Outcome of Patients with Small Coronary Arteries(Chronic coronary heart disease/Remodeling-4 (IHD) PJ86,Poster Session (Japanese),The 70th Anniver